Phylos Bioscience
Cannabis genetics company that empowers growers of all sizes to produce high quality cannabis in a cost-effective way.
Launch date
Employees
Market cap
-
Enterprise valuation
€35m (Public information from Feb 2023)
Portland Oregon (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $250k | Seed | |
N/A | Series C | ||
| N/A | N/A | - | |
* | $7.6m | Late VC | |
* | N/A | $4.5m Valuation: $38.0m | Late VC |
* | $3.3m | Convertible | |
* | $2.8m | Convertible | |
* | $1.0m | Convertible | |
| Total Funding | €17.6m | ||
Recent News about Phylos Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.